tiprankstipranks
Pharmaxis Ltd (AU:SNT)
:SNT
Australian Market

Pharmaxis Ltd (SNT) Technical Analysis

Compare
10 Followers

Summary of all the Indicators

Overall Consensus
Neutral
8Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Pharmaxis Ltd’s (SNT) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Pharmaxis Ltd is a Buy.
Pharmaxis Ltd’s (SNT) 20-Day exponential moving average is 0.07, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (SNT) 50-Day exponential moving average is 0.07, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.

Pharmaxis Ltd (SNT) Pivot Points

Feb 16, 2025, 10:04 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.07
0.08
0.08
0.08
0.08
0.08
Fibonacci
0.07
0.07
0.07
0.08
0.08
0.08
0.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharmaxis Ltd (SNT) Moving Averages

Feb 16, 2025, 10:04 PM
Period
Simple
Exponential
MA5
0.07Sell
0.07Sell
MA10
0.07Sell
0.07Sell
MA20
0.07Sell
0.07Sell
MA50
0.07Sell
0.07Buy
MA100
0.06Buy
0.06Buy
MA200
0.04Buy
0.05Buy
Pharmaxis Ltd’s (SNT) 10-Day exponential moving average is 0.07, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (SNT) 100-Day exponential moving average is 0.06, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 50-day simple moving average is 0.07, creating a Sell signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 100-day simple moving average is 0.06, creating a Buy signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 200-day simple moving average is 0.04, creating a Buy signal.

Pharmaxis Ltd (SNT) Technical Indicators

Feb 16, 2025, 10:04 PM
Name
Value
Implied Action
RSI (14)
48.32
Neutral
STOCH (9,6)
61.90
Neutral
STOCHRSI (14)
64.58
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
11.37
Buy
Williams %R
-56.25
Buy
CCI (14)
2.44
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
54.29
Neutral
ROC
0.00
Buy
Pharmaxis Ltd’s (SNT) Relative Strength Index (RSI) is 48.32, creating a Neutral signal.
Pharmaxis Ltd’s (SNT) Trend Strength Indicator (ADX) is 11.37, creating a Buy signal.
Pharmaxis Ltd’s (SNT) Commodity Channel Index (CCI) is 2.44, creating a Neutral signal.

FAQ

Is SNT a Buy, Hold, or Sell?
Based on SNT’s technical indicators, SNT is a Hold.
    What is SNT’s RSI (14)?
    SNT’s RSI (14) is 48.32, which suggests SNT is a Neutral.
      What is SNT’s MACD?
      SNT’s MACD is <0.01, which suggests SNT is a Buy.
        What is SNT’s 5-day moving average?
        SNT’s 5-day moving average is 0.07, which suggests SNT is a Sell.
          What is SNT’s 20-day moving average?
          SNT 20-day moving average is 0.07, which suggests SNT is a Sell.
            What is SNT’s 50-day moving average?
            SNT’s 50-day moving average is 0.07, which suggests SNT is a Sell.
              What is SNT’s 200-day moving average?
              SNT’s 200-day moving average is 0.04, which suggests SNT is a Buy.
                What is SNT’s Williams % R (14)?
                SNT’s Williams % R (14) is -56.25, which suggests SNT is a Buy.
                  What is SNT’s CCI (14)?
                  SNT’s CCI (14) is 2.44, which suggests SNT is a Neutral.
                    What is the share price of Pharmaxis Ltd?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis